doi	title	authors	title_name	year	downloads	visitors	countries
10.1016/j.hemonc.2014.11.006	Natural killer cells: In health and disease	Arundhati Mandal, Chandra Viswanathan	Hematology/Oncology and Stem Cell Therapy	2015	5	5	5
10.1016/j.hemonc.2014.03.001	Leukemia during pregnancy: Long term follow up of 32 cases from a single institution	A.J.M. Saleh, Ayman Alhejazi, Syed Osman Ahmed, Fahad Al Mohareb, Fahad AlSharif, Hazza AlZahrani, Said Yousuf Mohamed, Walid Rasheed, Ghuzayel AlDawsari, Khalid Ibrahim, Shad Ahmed, Wahiba Chebbo, Ghada ElGohary, Muhamad Almahayni, Naeem Chaudhri, Mahmoud Aljurf	Hematology/Oncology and Stem Cell Therapy	2014	4	3	3
10.1016/j.hemonc.2013.12.002	Epstein–Barr virus and Hodgkin lymphoma in Jordan	Maher A. Sughayer, Hussam A. Haddad, Rana M. Al-Yousef, Mohammed El-Khateeb, Hanood Abu-Rass	Hematology/Oncology and Stem Cell Therapy	2014	2	2	2
10.1016/j.hemonc.2013.12.003	Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature	Housam Haddad, Suchitra Sundaram, Cynthia Magro, Usama Gergis	Hematology/Oncology and Stem Cell Therapy	2014	2	2	2
10.1016/j.hemonc.2014.04.002	Dengue fever as a cause of febrile neutropenia in adult acute lymphoblastic leukemia: A single center experience	Hasmukh Jain, Manju Sengar, Hari Menon, Uma Dangi, Sanjay Biswas, M.V. Chandrakanth	Hematology/Oncology and Stem Cell Therapy	2014	2	2	2
10.1016/j.hemonc.2014.09.007	PIK3CA mutations in Peruvian patients with HER2-amplified and triple negative non-metastatic breast cancers	Carlos A. Castaneda, Marco Lopez-Ilasaca, Joseph A. Pinto, Michelle Chirinos-Arias, Franco Doimi, Silvia P. Neciosup, Katerin I. Rojas, Tatiana Vidaurre, Justin M. Balko, Carlos L. Arteaga, Henry L. Gomez	Hematology/Oncology and Stem Cell Therapy	2014	2	2	2
10.1016/j.hemonc.2014.11.003	Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer	H.A. Alagizy, M.A. Shehata, T.A. Hashem, K.K. Abdelaziz, M.M. Swiha	Hematology/Oncology and Stem Cell Therapy	2015	2	2	2
10.1016/j.hemonc.2014.11.005	THPO–MPL pathway and bone marrow failure	Majed Dasouki, Irfan Saadi, Syed O. Ahmed	Hematology/Oncology and Stem Cell Therapy	2015	4	2	2
10.1016/j.hemonc.2013.08.002	Choroidal metastasis secondary to prostatic adenocarcinoma: Case report and review of literature	Faisal Albadainah, Jamal Khader, Samer Salah, Ahmed Salem	Hematology/Oncology and Stem Cell Therapy	2015	1	1	1
10.1016/j.hemonc.2013.10.001	The incidence rate of prostate cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001–2008	Ibrahim G. Alghamidi, Issam I. Hussain, Mohamed S. Alghamdi, Mohammed A. El-Sheemy	Hematology/Oncology and Stem Cell Therapy	2014	1	1	1
10.1016/j.hemonc.2013.11.001	Severe combined immunodeficiency caused by a new homozygous RAG1 mutation with progressive encephalopathy	Nivedita Dhingra, Satya Prakash Yadav, Jean-Pierre de Villartay, Capucine Picard, RK Sabharwal, Veronique Dinand, Samarjit Singh Ghuman, Anupam Sachdeva	Hematology/Oncology and Stem Cell Therapy	2014	2	1	0
10.1016/j.hemonc.2014.01.002	Psychiatric morbidity in Egyptian children with acute lymphoblastic leukemia and their care providers	Ahmed S. Khalifa, Zeinab Bishry, Azza A.G. Tantawy, Mohammed H. Ghanem, Safia M. Effat, Heba El Shahawy, Fatma S.E. Ebeid	Hematology/Oncology and Stem Cell Therapy	2014	1	1	1
10.1016/j.hemonc.2014.06.003	Voice disorders induced by bevacizumab administration in an ovarian cancer patient: An underestimated and rare toxicity	P. Kountourakis, G. Antoniou, K. Papadimitriou, V. Vassiliou, D. Syrigos, M. Philippou, D. Papamichael	Hematology/Oncology and Stem Cell Therapy	2014	1	1	1
10.1016/j.hemonc.2014.09.002	Rare but authentic Philadelphia-positive acute myeloblastic leukemia: Two case reports and a literature review of characteristics, treatment and outcome	Emilie Reboursiere, Sylvain Chantepie, Anne-Claire Gac, Oumedaly Reman	Hematology/Oncology and Stem Cell Therapy	2015	1	1	1
10.1016/j.hemonc.2014.11.007	Plerixafor in the treatment of progenitor cell mobilization failure: First experience in Algeria	M.A. Bekadja, R. Bouhass, S. Osmani, M. Brahimi, S. Talhi, N. Yafour, A. Arabi	Hematology/Oncology and Stem Cell Therapy	2015	3	1	1
10.1016/j.hemonc.2014.12.002	The mutation profile of JAK2, MPL and CALR in Mexican patients with Philadelphia chromosome-negative myeloproliferative neoplasms	Nancy Labastida-Mercado, Samantha Galindo-Becerra, Javier Garcés-Eisele, Perla Colunga-Pedraza, Valeria Guzman-Olvera, Virginia Reyes-Nuñez, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles	Hematology/Oncology and Stem Cell Therapy	2015	1	1	1
10.1016/j.hemonc.2014.12.004	Frequency of Gγ-globin promoter −158 (C>T) XmnI polymorphism in patients with homozygous/compound heterozygous beta thalassaemia	Nadir Ali, Muhammad Ayyub, Saleem Ahmed Khan, Suhaib Ahmed, Kazim Abbas, Hamid Saeed Malik, Sunila Tashfeen	Hematology/Oncology and Stem Cell Therapy	2015	1	1	1
10.1016/j.hemonc.2015.01.001	Alveolar rhabdomyosarcoma masquerading as Burkitt’s lymphoma in bone marrow	I.K. Tailor, I. Motabi, N. Alshehry, S. Zaidi, L. Algwaiz	Hematology/Oncology and Stem Cell Therapy	2015	1	1	1
10.1016/j.hemonc.2015.04.001	Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases	Nahlah Alghasham, Randa Alnounou, Hazzaa Alzahrani, Fahad Alsharif	Hematology/Oncology and Stem Cell Therapy	2015	2	1	1
